US Tech 100

17,173.20

1.85%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

TNG Transgene SA

1.22

-0.02 (-1.61%)

May 02 2024 - Closed

Delayed by 15 minutes

Document d'enregistrement Universel 2023

Pièces jointes

DEU Transgene 2023-FR
969500PDJW8N0FSGGK69-2023-12-31-fr

Transgene (EU:TNG)
Historical Stock Chart
From Apr 2024 to May 2024

Transgene (EU:TNG)
Historical Stock Chart
From May 2023 to May 2024

News

Availability of Preparatory Documents for the Combined General Meeting of May 15, 2024
Wednesday 24 April 2024 (1 week ago) • GlobeNewswire Inc.

Document d'enregistrement Universel 2023
Thursday 11 April 2024 (3 weeks ago) • GlobeNewswire Inc.

MIse à disposition du document d'enregistrement universel 2023 de Transgene
Thursday 11 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024
Tuesday 9 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Transgene nomme Lucie Larguier en tant que Directrice Financière et Christelle Schwoerer Comme Directrice des Ressources Humaines
Wednesday 27 March 2024 (1 month ago) • GlobeNewswire Inc.

Transgene annonce ses prochaines rencontres avec les investisseurs
Monday 18 March 2024 (1 month ago) • GlobeNewswire Inc.

Transgene présentera de nouvelles données sur son vaccin individualisé TG4050 à l’AACR 2024
Wednesday 6 March 2024 (2 months ago) • GlobeNewswire Inc.

Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050
Tuesday 5 March 2024 (2 months ago) • Business Wire

Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050
Tuesday 5 March 2024 (2 months ago) • GlobeNewswire Inc.

Transgene annonce la nomination de James Wentworth comme Directeur du Business Development
Monday 22 January 2024 (3 months ago) • GlobeNewswire Inc.

Transgene Announces Financial Calendar for 2024
Monday 22 January 2024 (3 months ago) • GlobeNewswire Inc.

Transgene et NEC étendent leur collaboration et poursuivent ensemble le développement clinique de TG4050, un vaccin thérapeutique individualisé contre le cancer
Monday 8 January 2024 (4 months ago) • GlobeNewswire Inc.

BlackStar Enterprise (PK)

Brookmount Explorations (PK)

NASDAQ

DJT

Trump Media and Technology

USOTC

ACRL

Atacama Resources (PK)

International Star (PK)

USOTC

GDVM

Global Developments (PK)

Globestar Therapeutics (PK)

Therapeutic Solutions (PK)

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

TNG Transgene SA

News

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

TNG Transgene SA

News

Your Recent History

Company

Business

Popular

Get The App